Cargando…
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
BACKGROUND: Male germ cell tumor (GCT) is a highly curable malignancy, which exhibits exquisite sensitivity to cisplatin treatment. The genetic pathway(s) that determine the chemotherapy sensitivity in GCT remain largely unknown. RESULTS: We studied epigenetic changes in relation to cisplatin respon...
Autores principales: | Koul, Sanjay, McKiernan, James M, Narayan, Gopeshwar, Houldsworth, Jane, Bacik, Jennifer, Dobrzynski, Deborah L, Assaad, Adel M, Mansukhani, Mahesh, Reuter, Victor E, Bosl, George J, Chaganti, Raju SK, Murty, Vundavalli VVS |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420487/ https://www.ncbi.nlm.nih.gov/pubmed/15149548 http://dx.doi.org/10.1186/1476-4598-3-16 |
Ejemplares similares
-
Characteristic promoter hypermethylation signatures in male germ cell tumors
por: Koul, Sanjay, et al.
Publicado: (2002) -
Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions
por: Arias-Pulido, Hugo, et al.
Publicado: (2002) -
Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression
por: Narayan, Gopeshwar, et al.
Publicado: (2006) -
Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome
por: Narayan, Gopeshwar, et al.
Publicado: (2003) -
Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization
por: Gowrishankar, Banumathy, et al.
Publicado: (2014)